Prospects for a vaccine against the Hepatitis C virus

Article Abstract:

The chances of producing a vaccine to combat Hepatitis C infection has improved, with the discovery that some humans and chimpanzees have natural immunity to infection by Hepatitis C virus. The immune system of some infected people can spontaneously clear the virus, whereas in others antiviral drugs, it works partly in the treatment of the virus.

Viral vaccines

---

Cheaper approaches to flu divide researchers

Article Abstract:

Scientists are looking at a different approach for developing drugs that modulate the immune system, as Tamiflu and other antivirals are very expensive and difficult to manufacture. They are studying joint treatments with immune modulators and antivirals instead of using immune drugs when viral is high.

Drug therapy, Influenza

---

Mechanism of action of interferon and ribavirin in treatment of Hepatitis C

Article Abstract:

A combination of interferon- alpha with the antiviral drug ribavirin is currently used in the treatment of Hepatitis C. This is however effective only in a fraction of patients and is weighed down with adverse effects.

Usage, Drug therapy, Combination, Combination drug therapy, Interferon alpha, Ribavirin

Similar abstracts:

• Abstracts: Nanostructures in a new league. Magnetization distribution in the mixed-phase state of hole-doped manganites. View from the edge
• Abstracts: Laboratory investigation of the interaction of off-axis mantle plumes and spreading centres. Laboratory models of the thermal evolution of the mantle during rollback subduction
• Abstracts: What's best on the banks? Decoupling of erosion and precipitation in the Himalayas
• Abstracts: Evolving concepts of rheumatoid arthritis. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
• Abstracts: Context-dependent nestmate discrimination and the effect of action thresholds on exogenous cue recognition in the Argentine ant

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.